173 related articles for article (PubMed ID: 23708420)
1. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
2. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
3. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
4. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
5. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
8. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma.
Torer N; Kayaselcuk F; Nursal TZ; Yildirim S; Tarim A; Nòyan T; Karakayali H
J Surg Oncol; 2007 Oct; 96(5):419-23. PubMed ID: 17874463
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
11. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
15. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
Yang L; Guo T; Jiang S; Yang Z
Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
[TBL] [Abstract][Full Text] [Related]
16. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
18. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
19. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
[TBL] [Abstract][Full Text] [Related]
20. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]